+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cough Suppressant Drugs Market by Product Form, Distribution Channel, Prescription Status, Active Ingredient, End User - Global Forecast to 2030- Product Image
Cough Suppressant Drugs Market by Product Form, Distribution Channel, Prescription Status, Active Ingredient, End User - Global Forecast to 2030- Product Image
Sale

Cough Suppressant Drugs Market by Product Form, Distribution Channel, Prescription Status, Active Ingredient, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 198 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4989771
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The cough suppressant drugs market is undergoing considerable transformation as healthcare providers, patients, and manufacturers respond to rapid advances in formulation technology, digital health integration, and evolving care delivery models. Senior decision-makers must strategically align with these shifts to capture growth potential and maintain a resilient competitive position within this critical pharmaceutical segment.

Market Snapshot: Cough Suppressant Drugs Market

The Cough Suppressant Drugs Market grew from USD 2.07 billion in 2024 to USD 2.17 billion in 2025. It is expected to continue growing at a CAGR of 4.65%, reaching USD 2.72 billion by 2030. Industry momentum is propelled by an increased focus on product innovation, supply chain agility, and the integration of digital health tools designed to support both patient adherence and outcomes. Heightened attention to product availability and regulatory compliance, especially in the context of shifting global trade conditions, is influencing decision-making across all levels.

Scope & Segmentation

This report delivers actionable insights across the full spectrum of the cough suppressant category. It examines both product landscape and operational context, including regulatory adaptation, market entry strategies, technological integration, and regional opportunities.

  • Product Forms: Capsules, drops, lozenges (flavored and unflavored), syrups (sugar-based and sugar-free), tablets (chewable, conventional, orally disintegrating).
  • Distribution Channels: Hospital pharmacies, online pharmacies, retail pharmacies.
  • Prescription Status: Over-the-counter, prescription.
  • Active Ingredients: Benzonatate, codeine, dextromethorphan, diphenhydramine, guaifenesin, herbal extracts (eucalyptus oil, honey, thyme extract).
  • End Users: Ambulatory centers, clinics, homecare, hospitals.
  • Regions: Americas (including major states in the US), Europe, Middle East & Africa, Asia-Pacific.
  • Companies Tracked: Leading multinational firms, specialty companies, and emerging biotechnology innovators.
  • Technology & Innovation: Extended-release drug formulations, controlled-release dosage forms, digital health platforms, AI-driven symptom tracking, and advanced packaging options.

Cough Suppressant Drugs Market: Key Takeaways

  • Ongoing product innovation focuses on patient convenience, mask taste, and improved adherence through advanced formulation science.
  • Digital health and patient engagement tools are being integrated to drive better therapeutic outcomes and support remote care delivery.
  • Market segmentation reveals notable shifts as consumer demand rises for herbal remedies and sugar-free formulations, reflecting health and lifestyle trends.
  • Regional market dynamics require tailored approaches, with APAC and emerging Middle East & Africa regions gaining importance due to consumer preferences and regulatory developments.
  • Collaborations between pharmaceutical manufacturers and digital therapeutics partners are becoming more influential for brand positioning and market access.
  • Agility in supply chain strategy and scenario planning has become essential for managing pricing volatility and regulatory changes.

Tariff Impact: Responding to US Trade Measures

Recent tariff changes in the US have prompted cough suppressant manufacturers to revisit sourcing models and accelerate domestic production. These adjustments are influencing cost structures, operational footprints, and product pricing across both over-the-counter and prescription channels. The shift has catalyzed investments in nearshoring, while contract research organizations and ingredient suppliers increase capacity for local demand. Distribution and inventory strategies have evolved to manage longer lead times and optimize margin stability.

Methodology & Data Sources

This report utilizes a mixed-methods approach—incorporating primary interviews with pharmaceutical leaders, contract organizations, and regulatory experts alongside rigorous secondary research—from scientific literature, financial disclosures, and patent data. Trend extrapolation and scenario analysis contribute to robust, bias-checked strategic insights.

Why This Report Matters

  • Gain clarity on market segmentation and regulatory trends shaping regional and global growth.
  • Unlock opportunities for product innovation, digital transformation, and strategic alliances to drive portfolio differentiation.
  • Strengthen scenario planning and supply chain resilience to manage policy shifts and market uncertainties.

Conclusion

With evolving product forms, growing digital integration, and rapid policy adaptations, the cough suppressant drugs market demands strategic foresight. This report arms leaders with the knowledge to anticipate trends, mitigate risk, and capture new opportunities in a changing landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cough Suppressant Drugs Market, by Product Form
8.1. Introduction
8.2. Capsule
8.2.1. Hard Capsule
8.2.2. Soft Gelatin Capsule
8.3. Drop
8.4. Lozenge
8.4.1. Flavored
8.4.2. Unflavored
8.5. Syrup
8.5.1. Sugar-Based
8.5.2. Sugar-Free
8.6. Tablet
8.6.1. Chewable Tablet
8.6.2. Conventional Tablet
8.6.3. Orally Disintegrating Tablet
9. Cough Suppressant Drugs Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacies
9.3. Online Pharmacies
9.4. Retail Pharmacies
10. Cough Suppressant Drugs Market, by Prescription Status
10.1. Introduction
10.2. Over the Counter
10.3. Prescription
11. Cough Suppressant Drugs Market, by Active Ingredient
11.1. Introduction
11.2. Benzonatate
11.3. Codeine
11.4. Dextromethorphan
11.5. Diphenhydramine
11.6. Guaifenesin
11.7. Herbal Extracts
11.7.1. Eucalyptus Oil
11.7.2. Honey
11.7.3. Thyme Extract
12. Cough Suppressant Drugs Market, by End User
12.1. Introduction
12.2. Ambulatory Center
12.3. Clinic
12.4. Homecare
12.5. Hospital
13. Americas Cough Suppressant Drugs Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Cough Suppressant Drugs Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Cough Suppressant Drugs Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Kenvue Inc.
16.3.2. Haleon plc
16.3.3. Reckitt Benckiser Group plc
16.3.4. Sanofi S.A.
16.3.5. Bayer Aktiengesellschaft
16.3.6. Boehringer Ingelheim International GmbH
16.3.7. Novartis AG
16.3.8. Teva Pharmaceutical Industries Ltd.
16.3.9. Perrigo Company plc
16.3.10. Viatris Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. COUGH SUPPRESSANT DRUGS MARKET MULTI-CURRENCY
FIGURE 2. COUGH SUPPRESSANT DRUGS MARKET MULTI-LANGUAGE
FIGURE 3. COUGH SUPPRESSANT DRUGS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2024 VS 2030 (%)
FIGURE 12. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2024 VS 2030 (%)
FIGURE 14. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. COUGH SUPPRESSANT DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. COUGH SUPPRESSANT DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. COUGH SUPPRESSANT DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HARD CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SOFT GELATIN CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DROP, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY FLAVORED, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY UNFLAVORED, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SUGAR-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SUGAR-FREE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CHEWABLE TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CONVENTIONAL TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ORALLY DISINTEGRATING TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY OVER THE COUNTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY BENZONATATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CODEINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DEXTROMETHORPHAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DIPHENHYDRAMINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY GUAIFENESIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY EUCALYPTUS OIL, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HONEY, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY THYME EXTRACT, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AMBULATORY CENTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CLINIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 70. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 71. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 72. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2030 (USD MILLION)
TABLE 73. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2030 (USD MILLION)
TABLE 74. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 75. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 76. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 77. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 78. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
TABLE 79. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 81. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 82. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2030 (USD MILLION)
TABLE 83. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2030 (USD MILLION)
TABLE 84. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 85. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 86. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 87. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 88. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
TABLE 89. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 122. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2030 (USD MILLION)
TABLE 124. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 126. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 128. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
TABLE 130. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 132. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 133. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2030 (USD MILLION)
TABLE 134. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2030 (USD MILLION)
TABLE 135. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 136. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 138. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 139. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
TABLE 140. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 142. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 143. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2030 (USD MILLION)
TABLE 144. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2030 (USD MILLION)
TABLE 145. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 146. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 147. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 148. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 149. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
TABLE 150. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. ITALY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 162. ITALY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 163. ITALY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2030 (USD MILLION)
TABLE 164. ITALY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2030 (USD MILLION)
TABLE 165. ITALY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 166. ITALY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 167. ITALY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 168. ITALY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 169. ITALY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
TABLE 170. ITALY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. SPAIN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 172. SPAIN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 173. SPAIN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2030 (USD MILLION)
TABLE 174. SPAIN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2030 (USD MILLION)
TABLE 175. SPAIN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 176. SPAIN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 177. SPAIN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 178. SPAIN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 179. SPAIN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
TABLE 180. SPAIN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 191. SAUDI ARABIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 192. SAUDI ARABIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 208. SOUTH AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
TABLE 210. SOUTH AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. DENMARK COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 212. DENMARK COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 213. DENMARK COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2030 (USD MILLION)
TABLE 214. DENMARK COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2030 (USD MILLION)
TABLE 215. DENMARK COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 216. DENMARK COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 217. DENMARK COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 218. DENMARK COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 219. DENMARK COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
TABLE 220. DENMARK COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. NETHERLANDS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 222. NETHERLANDS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 223. NETHERLANDS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2030 (USD MILLION)
TABLE 224. NETHERLANDS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2030 (USD MILLION)
TABLE 225. NETHERLANDS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 226. NETHERLANDS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 227. NETHERLANDS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 228. NETHERLANDS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 229. NETHERLANDS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
TABLE 230. NETHERLANDS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 231. QATAR COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 232. QATAR COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 233. QATAR COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2030 (USD MILLION)
TABLE 234. QATAR COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2030 (USD MILLION)
TABLE 235. QATAR COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 236. QATAR COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 237. QATAR COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 238. QATAR COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 239. QATAR COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
TABLE 240. QATAR COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 241. FINLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 242. FINLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 243. FINLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2030 (USD MILLION)
TABLE 244. FINLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2030 (USD MILLION)
TABLE 245. FINLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 246. FINLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 247. FINLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 248. FINLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 249. FINLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
TABLE 250. FINLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 256. SWEDEN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 257. SWEDEN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 258. SWEDEN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 259. SWEDEN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
TABLE 260. SWEDEN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 261. NIGERIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 262. NIGERIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 263. NIGERIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2030 (USD MILLION)
TABLE 264. NIGERIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2030 (USD MILLION)
TABLE 265. NIGERIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 266. NIGERIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 267. NIGERIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 268. NIGERIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 269. NIGERIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
TABLE 270. NIGERIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. EGYPT COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 272. EGYPT COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 273. EGYPT COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2030 (USD MILLION)
TABLE 274. EGYPT COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2030 (USD MILLION)
TABLE 275. EGYPT COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 276. EGYPT COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 277. EGYPT COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 278. EGYPT COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 279. EGYPT COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
TABLE 280. EGYPT COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 281. TURKEY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 282. TURKEY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 283. TURKEY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2030 (USD MILLION)
TABLE 284. TURKEY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2030 (USD MILLION)
TABLE 285. TURKEY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 286. TURKEY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 287. TURKEY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 288. TURKEY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 289. TURKEY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
TABLE 290. TURKEY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 291. ISRAEL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 292. ISRAEL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 293. ISRAEL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2030 (USD MILLION)
TABLE 294. ISRAEL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2030 (USD MILLION)
TABLE 295. ISRAEL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 296. ISRAEL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 297. ISRAEL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 298. ISRAEL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 299. ISRAEL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
TABLE 300. ISRAEL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 301. NORWAY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 302. NORWAY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 303. NORWAY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2030 (USD MILLION)
TABLE 304. NORWAY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2030 (USD MILLION)
TABLE 305. NORWAY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 306. NORWAY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 307. NORWAY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 308. NORWAY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 309. NORWAY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
TABLE 310. NORWAY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 311. POLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 312. POLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 313. POLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2030 (USD MILLION)
TABLE 314. POLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2030 (USD MILLION)
TABLE 315. POLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 316. POLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 317. POLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 318. POLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 319. POLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
TABLE 320. POLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 321. SWITZERLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 322. SWITZERLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 323. SWITZERLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2030 (USD MILLION)
TABLE 324. SWITZERLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2030 (USD MILLION)
TABLE 325. SWITZERLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 326. SWITZERLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 327. SWITZERLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 328. SWITZERLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 329. SWITZERLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
TABLE 330. SWITZERLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 331. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 332. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 333. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET S

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Cough Suppressant Drugs market report include:
  • Kenvue Inc.
  • Haleon plc
  • Reckitt Benckiser Group plc
  • Sanofi S.A.
  • Bayer Aktiengesellschaft
  • Boehringer Ingelheim International GmbH
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Perrigo Company plc
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages198
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.17 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.72 Billion
Compound Annual Growth Rate4.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Cough Suppressant Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Cough Suppressant Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 179 Pages
  • Global
From
Cough Suppressant Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Cough Suppressant Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Medicated Confectionery Market by Product Type, Distribution Channel, Application, Active Ingredient, End User - Global Forecast to 2030 - Product Image

Medicated Confectionery Market by Product Type, Distribution Channel, Application, Active Ingredient, End User - Global Forecast to 2030

  • Report
  • 184 Pages
  • Global
From
Throat Lozenges Market by Form, Distribution Channel, Active Ingredient, Flavor, End User, Price Range - Global Forecast to 2030 - Product Image

Throat Lozenges Market by Form, Distribution Channel, Active Ingredient, Flavor, End User, Price Range - Global Forecast to 2030

  • Report
  • 189 Pages
  • Global
From
Biostimulants Market by Active Ingredients (Humic Substances, Seaweed Extracts, Amino Acids, Minerals & Vitamins), Crop Type, Mode of Application (Foliar treatment, Soil treatment, Seed treatment), Form, and Region - Global Forecast to 2030 - Product Image

Biostimulants Market by Active Ingredients (Humic Substances, Seaweed Extracts, Amino Acids, Minerals & Vitamins), Crop Type, Mode of Application (Foliar treatment, Soil treatment, Seed treatment), Form, and Region - Global Forecast to 2030

  • Report
  • 318 Pages
  • Global
From

About the Antitussive Market

The Antitussive market is a subset of the Cough and Cold Drugs market, which is composed of medications used to treat symptoms of the common cold, such as cough, sore throat, and congestion. Antitussives are a type of cough suppressant, which work by reducing the urge to cough and suppressing the reflex that causes coughing. Common ingredients in antitussives include dextromethorphan, codeine, and pholcodine. Antitussives are available in a variety of forms, including syrups, tablets, capsules, and lozenges. They are available both over-the-counter and by prescription, depending on the active ingredient. Some companies in the Antitussive market include GlaxoSmithKline, Pfizer, Novartis, Sanofi, and Johnson & Johnson. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.